Literature DB >> 2515647

Resistance to antituberculosis drugs in Riyadh, Saudi Arabia.

I O al-Orainey1, E S Saeed, F A el-Kassimi, N al-Shareef.   

Abstract

The prevalence of resistance to antituberculosis drugs in Riyadh was found to be 21.3%, while the rate of primary drug resistance was 11.5%. Resistance to isoniazid was the most common (19.4%) followed by rifampicin and streptomycin. The prevalence of primary and acquired rifampicin resistance was 3 and 33.7% respectively. The majority of isolates from patients with acquired resistance to rifampicin were resistant also to isoniazid.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2515647     DOI: 10.1016/0041-3879(89)90052-4

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  4 in total

1.  A random sample survey of initial drug resistance among tuberculosis cases in Latin America.

Authors:  A Laszlo; I N de Kantor
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

2.  Tuberculosis in children: a 13-year follow up of 1714 patients in a Belgian home care centre.

Authors:  M Toppet; A Malfroot; B Hofman; G Casimir; F Cantraine; I Dab
Journal:  Eur J Pediatr       Date:  1991-03       Impact factor: 3.183

3.  Susceptibility Pattern and Epidemiology of Mycobacterium tuberculosis in United Emirati Hospital.

Authors:  Mubarak Saif Alfaresi; Mohammed Hag-Ali
Journal:  Open Microbiol J       Date:  2010-03-08

4.  Drug-susceptibility pattern of mycobacterium tuberculosis among pulmonary tuberculosis patients in riyadh, saudi arabia.

Authors:  S T Al-Awaidy; N Al-Hamdan
Journal:  J Family Community Med       Date:  1997-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.